200 related articles for article (PubMed ID: 27293315)
1. Pleiotropic Effects of IL-2 on Cancer: Its Role in Cervical Cancer.
Valle-Mendiola A; Gutiérrez-Hoya A; Lagunas-Cruz Mdel C; Weiss-Steider B; Soto-Cruz I
Mediators Inflamm; 2016; 2016():2849523. PubMed ID: 27293315
[TBL] [Abstract][Full Text] [Related]
2. IL-2 enhances cervical cancer cells proliferation and JAK3/STAT5 phosphorylation at low doses, while at high doses IL-2 has opposite effects.
Valle-Mendiola A; Weiss-Steider B; Rocha-Zavaleta L; Soto-Cruz I
Cancer Invest; 2014 May; 32(4):115-25. PubMed ID: 24548303
[TBL] [Abstract][Full Text] [Related]
3. A novel role of metalloproteinase in cancer-mediated immunosuppression.
Sheu BC; Hsu SM; Ho HN; Lien HC; Huang SC; Lin RH
Cancer Res; 2001 Jan; 61(1):237-42. PubMed ID: 11196168
[TBL] [Abstract][Full Text] [Related]
4. Evidence that cervical cancer cells secrete IL-2, which becomes an autocrine growth factor.
Rangel-Corona R; Corona-Ortega T; Soto-Cruz I; López-Labra A; Pablo-Arcos T; Torres-Guarneros CF; Weiss-Steider B
Cytokine; 2010 Jun; 50(3):273-7. PubMed ID: 20227890
[TBL] [Abstract][Full Text] [Related]
5. T cell activation in the absence of interleukin 2 (IL 2) results in the induction of high-affinity IL 2 receptor unable to transmit a proliferative signal.
Proust JJ; Shaper NL; Buchholz MA; Nordin AA
Eur J Immunol; 1991 Feb; 21(2):335-41. PubMed ID: 1999222
[TBL] [Abstract][Full Text] [Related]
6. Immune microenvironment of cervical cancer and the role of IL-2 in tumor promotion.
Trujillo-Cirilo L; Weiss-Steider B; Vargas-Angeles CA; Corona-Ortega MT; Rangel-Corona R
Cytokine; 2023 Oct; 170():156334. PubMed ID: 37598478
[TBL] [Abstract][Full Text] [Related]
7. Phorbol myristate acetate-induced expression of high-affinity interleukin 2 receptors and production of interleukin 2 by human acute lymphoblastic leukemia T cells.
Sahraoui Y; Allouche M; Perrakis M; Clemenceau C; Jasmin C; Georgoulias V
Leukemia; 1992 Apr; 6(4):295-303. PubMed ID: 1588792
[TBL] [Abstract][Full Text] [Related]
8. The IL-2 receptor complex: expression and function on normal and leukemic B cells.
de Totero D; Francia di Celle P; Cignetti A; Foa R
Leukemia; 1995 Sep; 9(9):1425-31. PubMed ID: 7658707
[TBL] [Abstract][Full Text] [Related]
9. Glycodelin-A interferes with IL-2/IL-2R signalling to induce cell growth arrest, loss of effector functions and apoptosis in T-lymphocytes.
Soni C; Karande AA
Hum Reprod; 2012 Apr; 27(4):1005-15. PubMed ID: 22313865
[TBL] [Abstract][Full Text] [Related]
10. Biological properties of interleukin 2 and its role in pathogenesis of selected diseases--a review.
Olejniczak K; Kasprzak A
Med Sci Monit; 2008 Oct; 14(10):RA179-89. PubMed ID: 18830208
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-2 (IL-2) receptor-betagamma signalling is activated by c-Kit in the absence of IL-2, or by exogenous IL-2 via JAK3/STAT5 in human papillomavirus-associated cervical cancer.
Rocha-Zavaleta L; Huitron C; Cacéres-Cortés JR; Alvarado-Moreno JA; Valle-Mendiola A; Soto-Cruz I; Weiss-Steider B; Rangel-Corona R
Cell Signal; 2004 Nov; 16(11):1239-47. PubMed ID: 15337523
[TBL] [Abstract][Full Text] [Related]
12. Gangliosides inhibit T-lymphocyte proliferation by preventing the interaction of interleukin-2 with its cell surface receptors.
Chu JW; Sharom FJ
Immunology; 1993 May; 79(1):10-7. PubMed ID: 8509130
[TBL] [Abstract][Full Text] [Related]
13. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
[TBL] [Abstract][Full Text] [Related]
14. Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment.
Ren C; Cheng X; Lu B; Yang G
Eur J Cancer; 2013 Dec; 49(18):3889-99. PubMed ID: 23953057
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of lymphokine production by distinct subunits of the T cell interleukin 2 receptor.
Burdach S; Zessack N; Dilloo D; Shatsky M; Thompson D; Levitt L
J Clin Invest; 1991 Jun; 87(6):2114-21. PubMed ID: 1828253
[TBL] [Abstract][Full Text] [Related]
16. IL-2-dependent proliferation of murine T cells requires expression of both the p55 and p70 subunits of the IL-2 receptor.
Jankovic DL; Rebollo A; Kumar A; Gibert M; Thèze J
J Immunol; 1990 Dec; 145(12):4136-44. PubMed ID: 2258612
[TBL] [Abstract][Full Text] [Related]
17. The alpha chain of the IL-2 receptor determines the species specificity of high-affinity IL-2 binding.
Liu KD; Greene WC; Goldsmith MA
Cytokine; 1996 Aug; 8(8):613-21. PubMed ID: 8894436
[TBL] [Abstract][Full Text] [Related]
18. The human interleukin-2 receptor: insights into subunit structure and growth signal transduction.
Fung MR; Greene WC
Semin Immunol; 1990 Mar; 2(2):119-28. PubMed ID: 2129904
[TBL] [Abstract][Full Text] [Related]
19. All subunits of the interleukin-2 receptor are expressed by canine cutaneous mast cell tumours.
Meyer A; Gruber AD; Klopfleisch R
J Comp Pathol; 2013 Jul; 149(1):19-29. PubMed ID: 23276382
[TBL] [Abstract][Full Text] [Related]
20. Ligand binding by the IL-2 receptor is modulated by intracellular determinants of the IL-2 receptor beta-chain.
Goldsmith MA; Amaral MC; Greene WC
J Immunol; 1995 Mar; 154(5):2033-40. PubMed ID: 7868880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
